logo
Improve Eye Health With These 6 Best Vitamins and Supplements

Improve Eye Health With These 6 Best Vitamins and Supplements

CNET14 hours ago
The bright summer sunshine can do wonders for your mental health, but the increase in allergens and harmful UV rays is not as kind to your eyes. Annoyances like watery eyes, dry eyes or blurry vision are common in this season, but it's possible to make your eyes more resilient to these issues.
Having a balanced diet that incorporates dark green leafy vegetables and essential fatty acids is important for more than just your nutrition and gut health. Everything you eat can impact specific organs, like your eyes. Fortunately, that means you can incorporate specific vitamins, supplements and foods into your diet to support your eye health and vision.
However, make sure you talk to your doctor before making any changes, even if it's just including more eye-boosting vitamins and supplements in your diet. They can help you figure out what a balanced diet looks like for you, especially if you want to focus on a specific aspect of your health.
The best vitamins and supplements for eye health
Getty Images
In addition to a balanced diet, here are the best vitamins and supplements for your eyes. Luckily, you can get most of these added supplements for less than $10.
VitaminVitamin A supports your vision, immune system, heart, lungs and overall growth and development. Specifically, vitamin A helps you see a full spectrum of light, as the vitamin produces pigments in the retina. It can also keep your eyes from drying out. You can find vitamin A in foods such as salmon, broccoli, eggs, carrots and fortified breakfast cereals.
You have probably heard of the magic of carrots. Yes, it's true: Carrots are great for your eyes. Carrots (and other vividly colored fruits and vegetables) are high in beta-carotene, which is a compound that your body uses to make vitamin A. Beta-carotene is also available in a supplement form, although it isn't as common as vitamin A and is often more expensive.
Vitamin C
Vitamin C is found in foods like citrus fruit, bell peppers and tomatoes.
Getty Images
Vitamin C is like sunscreen for your eyes: It helps protect them from UV damage. The more time you spend outside and under the sun, the greater the risk for damage. According to the American Academy of Ophthalmology, too long in the sun can cause irreversible damage. Vitamin C can also lower your risk of cataracts, a disease that causes the lens of your eyes to become cloudy.
While a recent study found that vitamin C supplementation was effective in patients who were already vitamin C deficient, more studies are needed to truly understand the relationship between vitamin C and a lower risk of cataracts. In addition to getting enough vitamin C, avoid tanning beds, and if you are outside, wear sunglasses and a hat to protect your eyes.
Omega-Optometrists regularly recommend their patients consume omega-3s, and if a patient isn't getting enough of these fatty acids in their diet, try a supplement. Omega-3s are mainly found in fatty fish such as tuna, salmon, mackerel or herring and some nuts and seeds.
The American Optometric Association points to omega-3s as a nutrient that can slow the progress of age-related macular degeneration. Studies have also found that they can help prevent dry eye disease. These nutrients are great for both conditions due to their anti-inflammatory effects.
Vitamin E
yulka3ice/iStock/Getty Images
Another powerful antioxidant, vitamin E is vital to all our cells and cell functions. It helps to protect our bodies from cancer-causing free radicals and plays an important role in vision. Studies have shown that vitamin E can help protect the retinas from free radicals that can cause eye disease.
Vitamin C, another antioxidant, has more properties that help regeneration. Vitamin E can only help to protect the cells already there. But vitamin E can slow the progression of age-related macular degeneration. The American Optometric Association recommends 400 IU of vitamin E a day.
Zinc
Zinc is found in almost all multivitamins because it is such an essential nutrient to the body. It is used to boost the immune system and help the body heal from wounds quickly. Zinc also aids in eye health.
Zinc helps vitamin A create melanin (a pigment that protects the eyes) and may shield the eyes from age-related macular degeneration. The American Optometric Association recommends 40 to 80 mg a day to slow the progression.
Read more: Best Zinc Supplements
Lutein and zeaxanthin
Lutein and zeaxanthin are known to be important to our eyes. Lutein and zeaxanthin are carotenoids found in red and yellowish fruits and vegetables, as these compounds give the produce their vibrant colors. Carotenoids, also powerful antioxidants, are vital to eye health. They protect the eyes from free radicals that can cause damage. Lutein and zeaxanthin, specifically, have been found to prevent damage to retinas.
These carotenoids can also slow the progression of age-related macular degeneration. The American Optometric Association recommends a daily amount of 10 mg of lutein and 2 mg of zeaxanthin. While you can find lutein and zeaxanthin in supplement form, one bottle is on the pricier side. You may find it better, easier and more affordable to just eat more fruits and vegetables.
Vitamins and supplements found in foods
undefined Vitamin/supplement Foods Vitamin A Salmon, broccoli, eggs, carrots and fortified breakfast cereals Vitamin C Kale, broccoli, oranges, lemons, strawberries and Brussels sprouts Omega-3s Tuna, salmon, herring, mackerel, chia seeds, flaxseed and walnuts Vitamin E Sunflower seeds, almonds, peanuts, collared greens, red bell peppers, mangoes and avocados Zinc Meat, shellfish, chickpeas, lentils, pumpkin seeds, cashews, almonds, eggs, cheese and milk Lutein and zeaxanthin Kale, spinach, peas, broccoli, orange juice, red peppers, honeydew melons and grapes
What to consider
Most vitamins and supplements are generally considered safe for people to take, as they're nutrients your body naturally requires. You should always talk to your doctor before starting any supplements. Some vitamins and supplements can interact with various medications. Check with your doctor or pharmacist before taking any new vitamins or supplements in conjunction with certain medications. Especially if you are pregnant or breastfeeding, consult a medical provider first. Your doctor should be able to safely guide you to the best vitamins and supplements for eye health, as well as proper dosages.
Eye health tips
In addition to the best vitamins and supplements for eye health, there are other ways you can protect your eyes and preserve your vision health:
Wear sunglasses: Sunglasses block harmful UV light, decreasing your risk of cataracts, eye cancer and sunburn.
Sunglasses block harmful UV light, decreasing your risk of cataracts, eye cancer and sunburn. Screen breaks: The American Optometric Association recommends the 20-20-20 rule, which states that every 20 minutes, you look away from your screen at something 20 feet away for 20 seconds.
The American Optometric Association recommends the 20-20-20 rule, which states that every 20 minutes, you look away from your screen at something 20 feet away for 20 seconds. Physical activity: The American Academy of Ophthalmology reported on a study that found a correlation between exercise and eye damage prevention, though more studies are needed.
The American Academy of Ophthalmology reported on a study that found a correlation between exercise and eye damage prevention, though more studies are needed. Avoid smoking: Smoking cigarettes can lead to eye diseases that result in vision loss and blindness, according to the Food and Drug Administration.
Smoking cigarettes can lead to eye diseases that result in vision loss and blindness, according to the Food and Drug Administration. Get regular eye exams: Even if you have perfect vision, it is important to regularly get an eye exam to catch potential issues early. How often you should get an eye exam depends on your age. For instance, people ages 20 to 39 should get an eye exam every five years, while those ages 65 and up should get an eye exam every one to two years.
Even if you have perfect vision, it is important to regularly get an eye exam to catch potential issues early. How often you should get an eye exam depends on your age. For instance, people ages 20 to 39 should get an eye exam every five years, while those ages 65 and up should get an eye exam every one to two years. Remove your makeup: Before bed, always remove your makeup to prevent eye irritation and inflammation.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

KindlyMD Closes $200 Million Convertible Note Offering
KindlyMD Closes $200 Million Convertible Note Offering

Associated Press

time13 minutes ago

  • Associated Press

KindlyMD Closes $200 Million Convertible Note Offering

Company Intends to Use Net Proceeds to Fund Purchase of Bitcoin and for General Corporate Purposes Follows the Completion of KindlyMD's Merger with Nakamoto to Form Institutional-Grade Bitcoin Treasury Vehicle SALT LAKE CITY, UT / ACCESS Newswire / August 15, 2025 / KindlyMD, Inc. (NASDAQ:NAKA) ('KindlyMD' or the 'Company'), a provider of integrated healthcare services and institutional-grade Bitcoin treasury vehicle, today announced that it has closed its previously announced offering of a senior secured convertible note in an aggregate principal amount of $200.0 million (the 'Convertible Note') in a private offering to YA II PN, Ltd., an investment fund managed by Yorkville Advisors ('YA II'). The closing of this Convertible Note offering follows the completion of KindlyMD's strategic combination with Nakamoto Holdings Inc. ('Nakamoto'), a Bitcoin-native holding company. The Company intends to use the net proceeds from the Convertible Note offering to purchase more Bitcoin, as well as for working capital and general corporate purposes. The issuance of the Convertible Note further expands the Company's Bitcoin treasury strategy and adds to the $540 million of gross proceeds from a private placement in public equity ('PIPE Financing'), which closed concurrently with the Company's combination with Nakamoto. David Bailey, Chief Executive Officer and Chairman of KindlyMD, said, 'The strong support we continue to receive from investors is validation of our pioneering Bitcoin treasury strategy. We are excited to leverage our enhanced balance sheet and differentiated go-to-market strategy to acquire as much Bitcoin as possible.' The Convertible Note bears interest at a rate of 0.00% per annum for the first two years, and 6.00% per annum for the third year and is payable on August 15, 2028, the third-year anniversary of the issuance date of the Convertible Debenture or earlier redemption date. The Convertible Note provides that YA II may convert all or any portion of the principal amount of the Convertible Note, together with any accrued and unpaid interest thereon, at an initial conversion price of $2.80, which is subject to adjustment and a floor price and maximum number of convertible shares of the Company's common stock. The Company also has the right to redeem the Convertible Note under certain circumstances. Advisors Cohen & Company Capital Markets ('CCM'), a division of Cohen & Company Securities, LLC served as lead financial advisor to Nakamoto and placement agent for the PIPE Financing. 10X Capital ('10X'), through its affiliated broker-dealer, also served as a financial advisor and placement agent. Reed Smith LLP and Holland & Hart LLP acted as legal advisor to KindlyMD. About KindlyMD KindlyMD® is a patient-first healthcare company integrating traditional primary care, pain management, behavioral health, and alternative therapies to provide comprehensive, whole-person care. In August 2025, KindlyMD completed its merger with Nakamoto Holdings Inc., a Bitcoin-native holding company, to establish a publicly traded Bitcoin treasury vehicle. This strategic combination unites KindlyMD's healthcare expertise with Nakamoto's vision of integrating Bitcoin into global capital markets, creating a diversified entity focused on both healthcare innovation and Bitcoin treasury management. For more information, please visit Forward-Looking Statements All statements, other than statements of historical fact, included in this press release that address activities, events or developments that that the Company expects, believes or anticipates will or may occur in the future are forward-looking statements, as defined under U.S. federal securities laws, related to KindlyMD. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and often include statements about our future operations, business strategies, plans, objectives, expectations, intentions, goals, projections, prospects, future events, or performance, as well as underlying assumptions. These statements-covering matters such as expectations, plans, strategic outlooks, financial projections, market conditions, regulatory environments, Bitcoin-related strategies, Bitcoin treasury management activities, and KindlyMD's anticipated holding of Bitcoin as part of its corporate treasury are inherently uncertain and involve numerous assumptions and risks. Forward-looking terms used may include, but are not limited to, 'estimate,' 'project,' 'predict,' 'believe,' 'expect,' 'anticipate,' 'potential,' 'create,' 'intend,' 'could,' 'would,' 'may,' 'plan,' 'will,' 'guidance,' 'look,' 'goal,' 'future,' 'build,' 'focus,' 'continue,' 'strive,' 'allow,' 'seek,' 'aim,' 'target,' or the negative of such terms or other variations thereof and words and terms of similar substance used in connection with any discussion of future plans, actions, or events identify forward-looking statements and similar expressions. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements include, but are not limited to, descriptions of KindlyMD and its operations, strategies and plans, integration, debt levels and leverage ratio, capital expenditures, cash flows and anticipated uses thereof, including the purchase, custody, and potential sale or other use of Bitcoin, synergies, opportunities and anticipated future performance, including the management team and board of directors of KindlyMD. These statements may also relate to broader macroeconomic trends, industry developments, technology adoption, competitive positioning, market expansion, product launches, research and development efforts, acquisitions or dispositions, legal or regulatory developments, and other initiatives that could affect our future business performance. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this communication. These include risks relating to Bitcoin market volatility, cybersecurity and custody of digital assets, potential changes in laws or accounting standards relating to cryptocurrency, and regulatory developments affecting Bitcoin or other digital assets, as well as the risk that changes in KindlyMD's capital structure and governance could have adverse effects on the market value of its securities; the ability of KindlyMD to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on KindlyMD operating results and business generally; the risk that KindlyMD may be unable to reduce expenses or access financing or liquidity; the impact of any related economic downturn; the risk of changes in governmental regulations or enforcement practices; adverse impacts from geopolitical events, health crises, supply chain disruptions, changes to laws or accounting standards, cybersecurity threats or data breaches, intellectual property disputes, competitive pressures, or changes in consumer behavior; and other important factors that could cause actual results to differ materially from those projected. All such factors are difficult to predict and are beyond KindlyMD's control, including those detailed in KindlyMD's Annual Reports on Form 10-K, Quarterly Reports on Form 10- Q, Current Reports on Form 8-K, and such other documents of KindlyMD filed, or to be filed, with the SEC that are or will be available on KindlyMD's website at and on the website of the SEC at All forward-looking statements are based on assumptions that KindlyMD believes to be reasonable but that may not prove to be accurate. Any forward-looking statement speaks only as of the date on which such statement is made, and KindlyMD does not undertake any obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Nothing contained herein constitutes an offer to buy or sell securities of KindlyMD or any other party, nor does it constitute a solicitation of any proxy or vote. ‍Contacts Media Carissa Felger / Sam Cohen Gasthalter & Co. Phone: (212) 257-4170 Email: [email protected] ‍Investors Valter Pinto, Managing Director KCSA Strategic Communications Phone: (212) 896-1254 Email: [email protected] SOURCE: KindlyMD, Inc press release

Dow Industrials Hit First Intraday High of 2025, Powered by UnitedHealth Shares
Dow Industrials Hit First Intraday High of 2025, Powered by UnitedHealth Shares

Wall Street Journal

time13 minutes ago

  • Wall Street Journal

Dow Industrials Hit First Intraday High of 2025, Powered by UnitedHealth Shares

A major rally in UnitedHealth UNH 11.98%increase; green up pointing triangle Group stock propelled the Dow Jones Industrial Average to its first intraday record of 2025. UnitedHealth, the Dow's biggest laggard since early April, jumped 12% on Friday after a filing showed that Warren Buffett's Berkshire Hathaway BRK.B -0.42%decrease; red down pointing triangle took a roughly $1.6 billion position in the healthcare company during the second quarter. UnitedHealth stock remains down 40% for the year.

Warren Buffett Is Betting Big on UnitedHealth Stock. Should You?
Warren Buffett Is Betting Big on UnitedHealth Stock. Should You?

Yahoo

timean hour ago

  • Yahoo

Warren Buffett Is Betting Big on UnitedHealth Stock. Should You?

UnitedHealth (UNH) shares soared as much as 14% on Friday after a regulatory filing confirmed legendary investor Warren Buffett has built a nearly $1.6 billion stake in the beleaguered healthcare giant. Buffett's conglomerate Berkshire Hathaway (BRK.A) (BRK.B) now owns about 5 million UNH shares in total. Other high-profile names that have capitalized on UnitedHealth's crash this year include 'Big Short' investor Michael Burry and David Tepper, the founder of Appaloosa Management. More News from Barchart UnitedHealth Stock Soars as Warren Buffett's Berkshire Hathaway Discloses $1.57B Stake Palantir CEO Alex Karp Sees More Gains Ahead With America-Focused Growth Strategy, Calls U.S. The 'Leader of the Free World' Lucid Motors Is Caught in a Tariff Trap. Is LCID Stock More Likely to Hit $1 or $7 in 2025? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! Including today's surge, UnitedHealth stock is up roughly 30% versus its year-to-date low set in early August. Compared to its share price on April 11, however, it's still down nearly 50%. What Buffett's Stake Mean for UnitedHealth Stock Buffett's $1.6 billion stake is massively constructive for UNH stock as it signals conviction in the insurer's long-term value despite its recent struggles. The 'Oracle of Omaha' has reputation for disciplined, value-driven investing, which often boosts market confidence, attracts institutional interest, and stabilizes sentiment. Plus, sizable investments from other notable investors like Burry and Tepper reinforces the narrative that UnitedHealth shares are undervalued, potentially poised for recovery. Their collective endorsement is a huge vote of confidence in the company's fundamentals, business model, and resilience, driving renewed investor optimism and upward momentum in the stock. Should You Invest in UNH Shares at Current Levels Buffett's investment may be a reason to load up on UnitedHealth stock also because 'it's available at a 50% discount,' according to a renowned professor at the University of Maryland, David Kass. Kass agrees that UNH will see 'major fines' and the NYSE-listed behemoth will have to fire some executives, but said longer term, 'the company will survive and likely regain its prominence in the industry.' He recommends owning UNH shares at current levels also because it offers robust finances, above-average profitability and 'a below average price-to-earnings (P/E) ratio.' A healthy 2.9% dividend yield makes up for another great reason to buy UnitedHealth stock here. UnitedHealth Remains a 'Buy'-Rated Stock Investors should also note that Wall Street hasn't entirely turned its back on UnitedHealth stock. The consensus rating on UNH shares currently sits at 'Moderate Buy' with price targets going as high as $440, indicating potential upside of another 42% from current levels. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store